Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data

C. J. Greenbaum, C. A. Beam, D. Boulware, S. E. Gitelman, P. A. Gottlieb, K. C. Herold, J. M. Lachin, P. McGee, J. P. Palmer, M. D. Pescovitz, H. Krause-Steinrauf, J. S. Skyler, J. M. Sosenko

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)S93-S94
JournalDiabetes Technology and Therapeutics
Volume15
Issue numberSUPPL.1
DOIs
StatePublished - Jun 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Greenbaum, C. J., Beam, C. A., Boulware, D., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lachin, J. M., McGee, P., Palmer, J. P., Pescovitz, M. D., Krause-Steinrauf, H., Skyler, J. S., & Sosenko, J. M. (2013). Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data. Diabetes Technology and Therapeutics, 15(SUPPL.1), S93-S94. https://doi.org/10.1089/dia.2013.1510